Synbiotic SE — Investor Presentation 2024

Nov 30, 2024

SYNBIOTIC

Corporate presentation

Overview

01 Vision \& Mission
02 Hemp \& Cannabis Market
03 Buy \& Build
04 Strategy
05 Network
06 Shares \& Stock Exchange
07 Team

"One of the oldest cultivated plants on earth could help to provide people with sufficient clothing, paper, oil, fuel, food, construction materials and medicine."

The rediscovery of the plant hemp cannabis marijuana
Jack Herer / Mathias Bröckers, 1993

01 Vision becomes Reality

"The rediscovery of hemp and cannabis has become a reality. We are in the midst of the dawn of the next great hemp and cannabis era."

Daniel Kruse, CEO SYNBIOTIC SE, 2024

Our vision is to make the versatile applications of industrial hemp, including CBD, and cannabis accessible to society at large.

We strive to advance the democratisation and availability of this valuable plant and maximise its potential across various industries.

We create sustainable synergies, diversification and the highest quality standards.

This is how we set new standards in our industry.

01 Mission is Mandate

Our mission is to create high, sustainable value through strategic investments in leading companies in the industrial hemp, CBD and cannabis sectors.

We offer our investors a carefully diversified platform that ensures both stability and growth potential across various business sectors.

The driving forces hereby are the needs of all stakeholders: Investors, customers and partners of SYNBIOTIC SE.

We see this as our mandate.

02 Industrial Hemp - a Future Billion-Dollar Market

Revenues of industrial hemp have been rising worldwide for years, despite the challenges that still exist.

Global industrial hemp market

Source: UNCTAD report 2022, *forecast

Application areas

Seeds	Fibres	Shives
Flowers \& leaves
Finished products
Protein	Oil	Supplements
Feed	Textile	Cosmetics
Construction material		Plastics
and much more.

Opportunities

Upcoming reassessment of the status of industrial hemp

• Clarification of Novel Food status for extracts and CBD
• Removal of the „misuse clause" „Nutzhanfliberalisierungsgesetz Germany" - Q1/2025
• Ongoing destigmatisation
• Research and development across all application areas
• Strong demand for sustainable raw materials and products

02 Growth of the German CBD and THC market

(Data source for own visualisation : https://de.statista.com/outlook/hmo/cannabis/deutschland, March 2024)

03 Business Sectors

SYNBIOTIC SE is a leading European corporate group operating in the dynamic environment of the industrial hemp and cannabis market.

As a public listed company, SYNBIOTIC SE offers its investors the exceptional opportunity to fully capitalize on the potential of this rapidly growing market.

Our holding strategically invests in promising ventures within the industrial hemp, medical and recreational cannabis sectors.

In doing so, we create profitable synergies across the entire value chain. Our expertise encompasses the entire process from cultivation and research to development, production, sales and distribution of premium industrial hemp and cannabis products.

A special feature of SYNBIOTIC SE is the rigorous quality management throughout the entire production processes and supply chain, both fully covered by majority holdings. A unique selling point in the industry.

Due to our successful Buy-and-Build strategy, we continuously expand our production and value chain, setting new standards in the industry.

SYNBIOTIC - Your Smartest Way to Invest in Cannabis.

03 Business Sectors \& Holdings

03 Revenue Distribution by Business Sector

The revenues are shared to the sectors industrial hemp (40\%), medical cannabis (45\%) and recreational cannabis (15\%).

■ Industrial hemp

Medical cannabis

• Recreational cannabis
  

04 Strategy

SYNBIOTIC SE pursues a dynamic Buy-and-Build strategy in order to accelerate the company's growth and strengthen its market position. Through targeted acquisitions and continuous development of business sectors, SYNBIOTIC systematically expands its portfolio and taps into new market segments.

Acquisitions: Strategic acquisition of companies with complementary strengths, products and technologies in order to expand the value chain, product ranges and to levering synergies.

Integration: Efficient integration of new companies into the existing structure to enhance market efficiency and foster innovation leadership.

Expansion: Expansion of the business sectors in order to fully utilise the potential of industrial hemp and cannabis and penetrate new markets.

Innovation: Development and marketing of innovative products in the areas of industrial hemp, medical and recreational cannabis.

Diversification: Building a strong Pan-European group of companies with experienced and promising ventures in order to cover the relevant growth markets and minimise risks for investors.

05 Network

International network \& associations

Our strong international network, established over three decades, and our memberships in the key industry associations are central elements in shaping the future of hemp and cannabis. CEO Daniel Kruse is President of the European Industrial Hemp Association (EIHA) and Vice-Chair of the Federation of International Hemp Organisations (FIHO). We have a vibrant cooperation with the German Cannabis Industry Association (BvCW).

2 FIHA
EFIHO
BVCW

Experience \& expertise

Our team collectively possesses over 100 years of experience in the hemp market combining decades-long expertise of our executives. With highly experienced professionals and a strong presence in the hemp and cannabis industry, we are ideally positioned to take a leading role in this dynamic and growing market through internal networking and synergies within our group.

Stakeholder involvement

SYNBIOTIC SE understands the importance of an intensive dialogue. The holding uses state-of-the-art communication tools and social media platforms to establish and maintain transparent, open and interactive relationships with its stakeholders. Through continuous dialogue via social media platforms and face-to-face meetings, we keep our stakeholders regularly informed and have successfully established long-term partnerships.

(A) (B) (C) (in

Increasing shareholder community

The shareholder base continues to grow through targeted communication strategies. With over 17,500 private investors, SYNBIOTIC SE has built up a diverse and committed shareholder community. Thanks to our diversified investment portfolio, we are an attractive investment target for German, European and international investors looking to participate in and benefit from the potential of the growing hemp and cannabis market.

06 Shares \& Stock Exchange

Market capitalisation	Number of shares	Free float	Institutional
48 million EUR	7,16 million	$49 \%$	$51 \%$

14
Cannabis Law
Announcement
11

1st of April 24:
Cannabis Law
comes into force

Source: Own presentation SYNBIOTIC SE, 30th Oktober according to Xetra. Market Cap $=7.159 .343$ shares $x 6,70$ EUR $/$ share

06 Financial Planning 2024 - 2026

SYNBIOTIC

GROUP PLANNING 2024 - 2026

	ACTUAL	PLAN	PLAN	PLAN	PLAN
	1 HY 2024	2 HY 2024	FY 2024	FY 2025	FY 2026
Revenue (without IC)	6.610	10.053	16.663	26.183	33.612
Revenue intercompany	402	1.230	1.632	3.262	3.719
Other operating income	87	291	377	1.145	2.071
Total Revenues	7.099	11.573	18.672	30.590	39.403
Cost of sales	4.196	6.115	10.311	15.480	18.748
GROSS PROFIT	2.903	5.458	8.361	15.110	20.655
Personnel costs	1.834	1.978	3.812	4.388	4.813
Other operating costs	2.828	3.066	5.894	8.326	11.598
Earnings before interest, taxes, depreciation and amortisation (EBITDA)	$-1.759$	414	$-1.345$	2.397	4.245
Depreciation and amortisation	357	361	718	713	701
Earnings before interest and taxes (EBIT)	$-2.116$	53	$-2.063$	1.684	3.544
Interest income (-) / interest expenses ( + )	$-136$	$-43$	$-178$	$-167$	$-182$
Taxes	0	0	0	100	200
Profit / loss / total income (NET INCOME)	$-1.984$	96	$-1.887$	1.751	3.526

06 Analysts' views

07 Team

With a team of experts and a strong presence in the hemp and cannabis industry, we are perfectly positioned to take a leading role in the dynamic and growing hemp and cannabis market.

Our team consists of:

• Managing Director (CEO)
• Board of Directors
• Management Team
• Advisory Board

Further details: www.synbiotic.com/team

SYNBIOTIC

(7) Münsterstr. 336 | 40470 Düsseldorf | Germany
(10) office@synbiotic.com

Managing Director (CEO):
Chairman of the Board of Directors:

Daniel Kruse
Oliver Conrad

Disclaimer and Legal Information

This presentation contains certain forward-looking statements that reflect assumptions, opinions, expectations and views of the company or third parties. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual results, financial situation, development or performance of SYNBIOTIC SE and the estimates given here.

SYNBIOTIC SE provides no guarantee and accepts no liability that the assumptions underlying the forward-looking statements are correct or that the views expressed in this presentation will prove to be correct or that the forecast developments will actually materialise. No representation or warranty, express or implied, is made as to the information, estimates, objectives and opinions contained herein and no liability is accepted for any errors, omissions or misstatements contained herein and, accordingly, no representative of SYNBIOTIC SE or any of its affiliates or any of its officers, directors or employees accepts any liability whatsoever arising directly or indirectly from the use of this document.

The information in this presentation does not constitute an offer to buy or sell securities or a solicitation of an offer to buy securities, but is for information purposes only. Furthermore, the information contained in this presentation does not constitute investment advice. Shares can offer great opportunities, but also inevitably entail associated risks.

Shares are therefore in principle a risky investment. It is possible to lose your investment or even lose it completely.